Clinical Trials Logo

Filter by:
NCT ID: NCT00800553 Completed - Sleep Deprivation Clinical Trials

fMRI-behavioral Study of Cholinergic Augmentation With Donepezil in Healthy Sleep Deprived Adults

Start date: November 2006
Phase: Phase 4
Study type: Interventional

The purpose of this study was to characterize how the anti-cholinesterase inhibitor (AChE-I) donepezil modulates brain regions involved in visual short-term memory, episodic memory and inhibitory efficiency following 24 hours of total sleep deprivation using fMRI as an additional marker for drug effect.

NCT ID: NCT00799162 Recruiting - Postoperative Pain Clinical Trials

Prediction of Post-Cesarean Section Pain

PPCSP
Start date: November 2008
Phase: N/A
Study type: Observational

The purpose of this study is to determine if dynamic psychophysical testing along with genetic screening will allow to identify pre-operatively women who will suffer severe acute pain post-operatively and the subset who may experience chronic pain following cesarean section.

NCT ID: NCT00798889 Completed - Solid Tumors Clinical Trials

Rollover Protocol for Prior SU011248 Protocols

Start date: March 2004
Phase: N/A
Study type: Interventional

The objective of this protocol is to provide SU011248 treatment for patients who have participated in a SU011248 protocol and are eligible to enter this protocol

NCT ID: NCT00796926 Completed - Blepharitis Clinical Trials

Trial to Compare the Efficacy of Systane Ultra and Refresh Drop in the Treatment of Dry Eye in Asian Eyes

Start date: July 2009
Phase: Phase 3
Study type: Interventional

Systane Ultra is at least as efficacious and safe as Refresh Tears in Asian people with Dry Eyes

NCT ID: NCT00795301 Active, not recruiting - Rectal Cancer Clinical Trials

A Study of Radiotherapy in Rectal Cancer Using Oxaliplatin, Capecitabine With or Without Cetuximab

Start date: July 2008
Phase: Phase 2
Study type: Interventional

Primary Objectives To estimate the pathological complete response rate following neoadjuvant radiotherapy with concurrent capecitabine and oxaliplatin, with or without cetuximab based on the KRAS mutation status in rectal cancer. Secondary Objectives 1. To evaluate the incidence of grade 3-4 toxicities with each of the two neoadjuvant regimens and during the 30-day post-operative period. 2. To estimate the clinical tumour response rate and sphincter preservation rate with each of the two neoadjuvant regimens. 3. To correlate EGRF gene amplification with pathological response rate in those treated with cetuximab. 4. To estimate the pattern of failure. 5. To establish an annotated tissue library with samples being obtained prior to therapy and following therapy (at the time of surgery).

NCT ID: NCT00795145 Completed - Clinical trials for Bacterial Infections

A Study To Assess The Effect Of Linezolid On QTc Interval

Start date: December 2008
Phase: Phase 1
Study type: Interventional

The FDA has asked Pfizer to assess the risk of linezolid on QT interval (obtained from ECG readings) which could predispose patients to ventricular arrhythmias. This study is conducted to satisfy this requirement.

NCT ID: NCT00794157 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease (COPD)

Confirmatory Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Start date: November 2008
Phase: Phase 3
Study type: Interventional

This study was designed to provide pivotal confirmation of efficacy and safety data for 2 doses of indacaterol (150 and 300 µg once daily [od]) in patients with moderate to severe chronic obstructive pulmonary disease (COPD). Data from this study will be used for the registration of indacaterol in Japan.

NCT ID: NCT00792558 Withdrawn - Clinical trials for Advanced Solid Tumors

Ascending Multiple-Dose Study of BMS-817378 in Subjects With Advanced Cancers

Start date: January 2009
Phase: Phase 1
Study type: Interventional

The purpose of this study is to find the maximum tolerated dose of BMS-817378 in subjects with advanced cancers

NCT ID: NCT00791778 Completed - Ovarian Neoplasms Clinical Trials

Comparison of Nexavar/Placebo as Maintenance Therapy for Patients With Advanced Ovarian or Primary Peritoneal Cancer

Start date: November 2008
Phase: Phase 2
Study type: Interventional

Comparison of Nexavar with a placebo as maintenance therapy for patients with advanced Ovarian or primary Peritoneal cancers in complete remission following surgery and one regimen of chemotherapy.

NCT ID: NCT00790920 Completed - Stroke Clinical Trials

Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke

DIAS-3
Start date: December 2008
Phase: Phase 3
Study type: Interventional

The purpose of the study is to determine whether desmoteplase is effective and safe in the treatment of patients with acute ischaemic stroke when given within 3-9 hours from onset of stroke symptoms.